Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis

Clinical trial NCT02283762 · COMPLETED

Trial details

NCT number: NCT02283762
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Scleroderma, Systemic

Start date: 2015-01-15
Primary completion: 2017-12-15
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.